During the past decade, Celiac Disease Center at Columbia University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celiac Disease Center at Columbia University" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Celiac Disease Center at Columbia University" are "Celiac Disease" (4 trials), "Autoimmune Diseases" (1 trials), "Celiac" (1 trials), "Digestive System Disease" (1 trials) and "Gastrointestinal Disease" (1 trials). Many other conditions were trialed in "Celiac Disease Center at Columbia University" in a lesser frequency.

Most popular intervention types in "Celiac Disease Center at Columbia University" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gluten Sensor Dose-Finding Intervention" (1 trials), "KAN-101" (1 trials), "Nexvax2" (1 trials) and "Rifaximin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celiac Disease Center at Columbia University" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Celiac Disease Center at Columbia University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Celiac Disease Center at Columbia University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Celiac Disease Center at Columbia University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".